Welcome on board, Ian Henion!
We are pleased to announce that Ian Henion has joined Myro as a Research Associate. Ian joins us from Cell Signaling Technology and will be a very valuable addition to the neuroscience team!
Developing therapeutics to address the unmet need and societal burdens posed by neurodegenerative, demyelinating and neuropsychiatric disorders.
Our comprehensive research and development expertise, covering all stages of drug development, is intended to foster coherent decision making. We have confidence in the successful entrepreneurial experience of our founders in building and growing startup biotech companies.
Our strategy leverages emerging evidence that points toward shared disease mechanisms such as synaptic dysfunction, neuroinflammation and demyelination.
We believe that targeting these shared critical nodes of CNS disorders will increase probability of clinical success and provide therapeutic opportunities for a large patient population with unmet medical needs.
Myrobalan is a plant held by the Medicine Buddha whenever he is pictured. According to Tibetan Buddhism tradition, Myrobalan is regarded as the only herb capable of healing illnesses that have their root cause in conflicting emotions.